Tofacitinib 70771-1627
Product NDC
70771-1627- Manufacturer
- Zydus Lifesciences Limited
- Dosage Form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 20, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA214264
Need to source Tofacitinib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tofacitinib Citrate | 11 mg/1 |
Drug Class
Janus Kinase Inhibitor [EPC]Janus Kinase Inhibitors [MoA]
Packaging Options(2)
30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70771-1627-3)
90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70771-1627-9)